0.00Open0.00Pre Close0 Volume0 Open Interest9.00Strike Price0.00Turnover289.18%IV-88.28%PremiumJul 19, 2024Expiry Date4.22Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9454Delta0.0670Gamma1.12Leverage Ratio-0.0142Theta-0.0009Rho-1.06Eff Leverage0.0007Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet